Table 1.
Characteristics of neurological and 82 non-neurological patients paired in a 1:1 ratio according to sex, 10-year age group, number of concomitant conditions (0, 1, ≥2), and food or drug allergies. Values are counts (percentages) or mean ± standard deviation.
| Parkinson’s Disease | Multiple Sclerosis | Control | |
|---|---|---|---|
| (n = 34) | (n = 48) | (n = 82) | |
| Vaccine | |||
| Gam-COVID-Vac | 28 (82%) | 33 (69%) | 82 (100%) |
| Pfizer-BioNTech | 6 (18%) | 15 (31%) | 0 (0%) |
| Female sex | 15 (44%) | 40 (83%) | 55 (67%) |
| Age, years | 73 ± 9 | 54 ± 14 | 62 ± 16 |
| Comorbidities, number | |||
| 0 | 11 (32%) | 12 (25%) | 23 (28%) |
| 1 | 7 (21%) | 13 (27%) | 20 (24%) |
| ≥2 | 16 (47%) | 23 (48%) | 39 (48%) |
| Comorbidities | |||
| Hypertension | 13 (38%) | 9 (19%) | 31 (38%) |
| Obesity (BMI ≥30 kg/m2) | 5 (15%) | 8 (17%) | 18 (22%) |
| Cardiovascular diseases | 6 (18%) | 3 (6%) | 21 (26%) |
| Immunosuppression | 1 (3%) | 26 (54%) | 1 (1%) |
| Osteoarticular diseases | 3 (9%) | 5 (10%) | 11 (13%) |
| Diabetes mellitus | 6 (18%) | 3 (6%) | 7 (9%) |
| Malignant tumor | 3 (9%) | 0 (0%) | 5 (6%) |
| Respiratory diseases | 2 (6%) | 1 (2%) | 3 (4%) |
| Mental disorders | 0 (0%) | 1 (2%) | 4 (5%) |
| Nephropathy | 1 (3%) | 2 (4%) | 1 (1%) |
| Neurological diseases (excluding PD and MS) | 0 (0%) | 0 (0%) | 3 (4%) |
| Liver diseases | 0 (0%) | 2 (4%) | 0 (0%) |
| Other conditions | 7 (21%) | 12 (25%) | 27 (33%) |
| Ongoing drug therapies | 34 (100%) | 40 (83%) | 56 (68%) |
| Food or drug allergies | 9 (26%) | 6 (13%) | 15 (18%) |
| Previous SARS-CoV-2 infection | 1 (3%) | 2 (4%) | 3 (4%) |
PD; Parkinson’s Disease; MS, Multiple Sclerosis; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.